Trial intelligence / Profile preview

IV Tramadol for Postoperative Pain Following Abdominoplasty

NCT03774836Phase 3Active, not recruiting

Sponsor
Avenue Therapeutics
Start
Dec 2018
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tramadol in postoperative pain (3 arms), sponsored by Avenue Therapeutics. Primary endpoint: Sum of Pain Intensity Differences through 24 hours. Started Dec 2018; status: active, not recruiting.

02

Drugs

tramadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03774836.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03774836.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call